Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: Final survival analysis of a phase III randomized trial

David Cameron, Michelle Casey, Cristina Oliva, Beth Newstat, Bradley Imwalle, Charles E. Geyer

Research output: Contribution to journalArticlepeer-review

227 Scopus citations

Fingerprint

Dive into the research topics of 'Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: Final survival analysis of a phase III randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences